The title compounds, substituted 1H-benzo[f]chromen-3-yl-2H-chromen-2-ones were obtained by reacting 3-aryl-1-(3-coumarinyl)propen-1-ones with 2-napthol catalyzed by DBU (1,8-diazabicyclo[5,4,0]undec-7-ene) and concentrated H2SO4 in ample yields. Their structures were characterized by IR, 1 H NMR, 13 C NMR, mass spectral and elemental analysis. All the synthesized compounds have been evaluated for their in-vitro antibacterial activity against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa and antifungal activity against Aspergillus Niger and Candida albicans by using serial broth dilution method. Among those compounds 3 band 3c exhibits prominent results.
Introduction
Chromene derivatives are known to exhibit a wide range of biological activities, such as antifungal, antibacterial [1] [2] [3] [4] [5] , antioxidative [6] , antileishmanial [7] , antitumor [8, 9] , hypotensive [9] , antiproliferation [10, 11] , local anesthetic [12] , antiallergenic [13, 14] , central nervous system activities and effects [15] , as well as efficacious in the treatment of Alzheimer's disease [16] and schizophrenia disorder [17] . Coumarins are of scientific interest as anti-HIV agents [18] , antituberculosis agents [19] , cholinesterase and monoamine oxidase inhibitors [20] , antioxidants and anti-inflammatory [21, 22] .
In continuation of our work on the synthesis of tetrazolo and triazolo pyrimidin-yl-2H-chromen-2-ones [23] , we have developed a new route to synthesis of substituted 1H-benzo [f]chromen-3-yl-2H-chromen-2-ones from 3-aryl-1-(3-coumarinyl)propen-1-ones with 2-napthol catalyzed by 1,8-diaza bicyclo [5, 4 ,0]undec-7-ene (DBU) and concentrated H2SO4 in high yields and also studied their antimicrobial activity.
Experimental

Instrumentations
Melting points were recorded in open capillary and were uncorrected. Column chromatography was performed using silicagel (100-200 mesh size) purchased from Thomas Baker and TLC was carried out using aluminum sheets pre-coated with silica gel 60F254 purchased from Merck. IR spectra (KBr) were recorded on a Bruker WM-4(X) spectrometer (577 model). 1 H NMR (300 MHz) and 13 C NMR (75 MHz) spectra were recorded on Bruker AC-300 spectrometer in DMSO- 6 with TMS as an internal standard. Mass spectra (ESI) were recorded on JEOL SX-102 spectrometer. CHN analysis was done by Carlo Erba EA 1108 automatic elemental analyzer.
Materials
The chemicals and solvents used were of commercial grade and were used without further purification unless, otherwise, stated. To a stirred solution of compound 1a-e (0.12 mmol), 2-naphthol (2) (0.12 mmol) and DBU (0.02 mmol) in DCM (2.0 mL) was reacted at room temperature for 12 h, the reaction was monitored by TLC. Then a drop of concentrated H2SO4 was added directly and stirring was continued for 3 h at room temperature. The crude reaction mixture was purified by column chromatography by using ethyl acetate and petroleum ether (1:9, v:v) to give the corresponding products (Scheme 1). 13 13 
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Antibacterial activity
The antibacterial susceptibility test was done by determining the zone of inhibition by using disc diffusion method [24] . The substituted 1H-benzo[f]chromen-3-yl-2H-chromen-2-ones (3a-e) was dissolved in dimethyl sulfoxide solvent to make a solution of 120 µM/mL. From this stock solution, serial dilutions have been done to 20, 10, 5, and 1.25 µM/mL with dimethyl sulfoxide in sterile test tubes. Sterilized filter discs were dipped in these solutions and subsequently dried to remove the dimethyl sulfoxide. Nutrient agar medium plates were prepared using Muller-Hinton agar and were allowed to solidify. The three different bacteria like E. coli, S. aureus, P. aeruginosa were selected, and 1 mL of each bacteria and culture broth were added to the plate and spread with the help of a sterile spreader. The filter paper discs soaked in solution of 1H-benzo[f]chromen-3-yl-2H-chromen-2-ones (3a-e) derivatives were placed aseptically over the inoculated plates using sterile forceps. The plates were incubated at 37 °C for 24 h with respect to standard drug Norfloxacin. The zone of inhibition was measured.
Antifungal activity
The antifungal susceptibility test was done by using disc diffusion method. PDA (Potato Dextrose Agar) plates were prepared and the standardized suspension of fungal spores was poured and uniformly spread. All the synthesized compounds 1H-benzo[f]chromen-3-yl-2H-chromen-2-ones (3a-e) were dissolved in dimethyl sulfoxide to make a concentration of 120 µM/mL and serially diluted to different concentrations of 20, 10, and 5 µM/mL. Sterile discs with 150 mm diameter were further sterilized and loaded with synthesized compounds and after drying these discs were stored at 4 °C. The fungi strains such as C. albicans and A. niger was incubated in PDA (Potato Dextrose Agar) at 25 °C for 5 days with respect to standard drug Fluconozole. The zone of inhibition was measured.
Results and discussion
Chemistry
To develop a new method for the synthesis of substituted 1H-benzo[f]chromen-3-yl-2H-chromen-2-ones (3a-e), experiments were conducted by reacting 3-aryl-1-(3-coumarinyl) propen-1-ones(1a-e) with 2-napthol (2) catalyzed by DBU and concentrated H2SO4 for 5 h in ample yields (Scheme 1). The new molecules (3a-e) were confirmed on the basis of IR, 1 H NMR, 13 C NMR, mass spectral data, and elemental analysis.
Antibacterial activity
The antibacterial activity of 1H-benzo[f]chromen-3-yl-2H-chromen-2-ones (3a-e) were tested on bacterial resistant's like Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa by micro dilution broth method. The results are tabulated in Table 1 
Antifungal activity
Antifungal activity of synthesized1H-benzo[f]chromen-3-yl-2H-chromen-2-ones (3a-e) tested against fungi like Candida albicans and Aspergillus niger using Fluconazole as a standard drug. All the synthesized compounds 3a-e shows admirable antifungal results against Fluconazole as a standard drug. Among these, compounds 3b and 3c shows most encouraging results against A. niger and C. albicans. The result of zone of inhibition of Fluconazole was 16 mm while the synthesized molecules 3b and 3c exhibits 18-20 mm. The results are shown in Table 3 and 4.
Conclusions
Using a concise synthetic method, we successfully designed substituted 1H-benzo[f]chromen-3-yl-2H-chromen-2-ones (3a-e) scaffolds and obtained by treating 3-aryl-1-(3-coumarinyl)propen-1-ones with 2-napthol in the presence of DBU as catalyst and concentrated H2SO4in ample yields. All the synthesized compounds have been evaluated for their in vitro antibacterial activity against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa and antifungal activity against Aspergillus niger and Candida albicans, among those compounds 3b and 3c exhibits prominent results.
